Authors:
Fackler, OT
Wolf, D
Weber, HO
Laffert, B
D'Aloja, P
Schuler-Thurner, B
Geffin, R
Saksela, K
Geyer, M
Peterlin, BM
Schuler, G
Baur, AS
Citation: Ot. Fackler et al., A natural variability in the proline-rich motif of Nef modulates HIV-1 replication in primary T cells, CURR BIOL, 11(16), 2001, pp. 1294-1299
Authors:
Li, J
Schuler-Thurner, B
Schuler, G
Huber, C
Seliger, B
Citation: J. Li et al., Bipartite regulation of different components of the MHC class I antigen-processing machinery during dendritic cell maturation, INT IMMUNOL, 13(12), 2001, pp. 1515-1523
Authors:
Glaser, A
Schuler-Thurner, B
Feuerstein, B
Zingsem, J
Zimmermann, R
Weisbach, V
Eckstein, R
Citation: A. Glaser et al., Collection of MNCs with two cell separators for adoptive immunotherapy in patients with stage IV melanoma, TRANSFUSION, 41(1), 2001, pp. 117-122
Authors:
Andersen, MH
Keikavoussi, P
Brocker, EB
Schuler-Thurner, B
Jonassen, M
Sondergaard, I
Straten, PT
Becker, JC
Kampgen, E
Citation: Mh. Andersen et al., Induction of systemic CTL responses in melanoma patients by dendritic cellvaccination: Cessation of CTL responses is associated with disease progression, INT J CANC, 94(6), 2001, pp. 820-824
Authors:
Schuler-Thurner, B
Dieckmann, D
Keikavoussi, P
Bender, A
Maczek, C
Jonuleit, H
Roder, C
Haendle, I
Leisgang, W
Dunbar, R
Cerundolo, V
von den Driesch, P
Knop, J
Brocker, EB
Enk, A
Kampgen, E
Schuler, G
Citation: B. Schuler-thurner et al., Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1(+) melanoma patients by mature monocyte-derived dendritic cells, J IMMUNOL, 165(6), 2000, pp. 3492-3496
Authors:
Feuerstein, B
Berger, TG
Maczek, C
Roder, C
Schreiner, D
Hirsch, U
Haendle, I
Leisgang, W
Glaser, A
Kuss, O
Diepgen, TL
Schuler, G
Schuler-Thurner, B
Citation: B. Feuerstein et al., A method for the production of cryopreserved aliquots of antigen-preloaded, mature dendritic cells ready for clinical use, J IMMUNOL M, 245(1-2), 2000, pp. 15-29